FDA Inspection 1177446 — American National Red Cross Blood Services SW Region

American National Red Cross Blood Services SW Region — FEI 1673040

The FDA completed an inspection of American National Red Cross Blood Services SW Region on July 15, 2022 in Tulsa, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 15, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tulsa, OK (United States)